Related Experiment Video
Updated: Oct 31, 2025

05:39
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
Published on: November 30, 2021
3.8K
Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants
Bingjie Wang1,2, Meghan A Koch2,3
1Molecular and Cellular Biology Program and Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA.
Cell Reports. Medicine
|July 1, 2021
Abstract:
Necrotizing enterocolitis (NEC) is an intestinal disorder that disproportionately affects premature infants and lacks in effective therapeutics. Mihi and colleagues1 demonstrated that the cytokine interleukin-22 promotes intestinal epithelial regeneration and reduces disease severity in an experimental model of NEC.

